missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ RECTAS

Description
RECTAS (rectifier of aberrant splicing) is a pre-mRNA splicing modulator of the IKBKAP (inhibitor of κ light polypeptide gene enhancer in B-cells, kinase complex associated protein) gene. It corrects aberrant IKBKAP splicing in vitro in cellular models of familial dysautonomia and in vivo in transgenic mice. In combination with Phenylbutyric acid (Cat. No. 2682), RECTAS rescues PARK7 aberrant splicing and neuronal cell loss in a midbrain organoid model of familial Parkinson's disease. Orally bioavailable and brain penetrant.
Specifications
Specifications
| Chemical Name or Material | 2-Chloro-N-(2-furanylmethyl)-7 H-purin-6-amine |
| CAS | 101862-47-9 |
| Quantity | 10 mg |
| Target | DNA, RNA and Protein Synthesis Compounds |
| Molecular Formula | C10H8ClN5O |
| Purity | 0.98 |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?